A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma
Clinical trial NCT05590572 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05590572
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-01
- Primary completion
- 2026-12-01
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.